Share-based payment arrangements are a cornerstone of modern compensation, aligning employee incentives with company performance. For equity-settled share options, IFRS 2 provides clear guidance on their initial recognition. However, the corporate landscape is dynamic, and sometimes the terms of these options need to change. This blog post delves into a specific, critical aspect of IFRS 2: how to account for modifications to equity-settled share options, specifically focusing on the concept of 'incremental fair value'.
The Foundation: Original Grant Recognition
Before we look at modifications, let’s quickly revisit the basics. When equity-settled share options are granted, the entity measures their fair value at the grant date. This value is then recognized as an expense over the vesting period, with a corresponding increase in equity. This original fair value expense continues to be recognized, irrespective of any subsequent modifications, unless the options are forfeited.
What Constitutes a Modification?
A modification occurs when there's a change in the terms and conditions of a share-based payment arrangement. This could include altering the exercise price, extending the option's life, changing the number of options, or adjusting vesting conditions (e.g., accelerating vesting or introducing new performance targets). Each of these changes has the potential to impact the fair value of the options, and IFRS 2 provides a specific framework for how to account for that impact.
The Incremental Fair Value Principle
The core principle for accounting for a modification is to recognize any *increase* in the total fair value of the share-based payment arrangement, measured at the date of modification. Here’s how it works:
1. **Determine Fair Value of Modified Options:** Calculate the fair value of the *modified* options as at the modification date. This requires using updated inputs, such as the current share price, volatility, and the new terms.
2. **Determine Fair Value of Original Options:** Calculate the fair value of the *original* (unmodified) options as at the modification date. This involves hypothetically valuing the options as if the modification had *not* occurred, but using market conditions existing at the modification date.
3. **Calculate Incremental Fair Value:** The difference between the fair value of the modified options (from step 1) and the fair value of the original options (from step 2) is the 'incremental fair value'. If the modified options have a higher fair value, this positive difference represents an additional expense the entity must recognize.
This incremental fair value is then expensed prospectively over the remaining vesting period from the modification date, in addition to the original grant date fair value expense that continues to be recognized. Effectively, you're layering a new expense on top of the existing one, reflecting the additional value provided to employees.
Modifications That Decrease Fair Value
What if a modification *decreases* the fair value of the options (e.g., increasing the exercise price significantly)? IFRS 2 generally states that entities should *not* reverse any previously recognized expense. The original expense, based on the grant-date fair value, continues to be recognized. The modification simply doesn't result in any *additional* expense. The only exception is if the modification makes the options less likely to vest, in which case the cumulative expense might be adjusted downwards to reflect the lower number of expected options to vest.
Conclusion
Accounting for modifications to equity-settled share options under IFRS 2 requires a meticulous approach, particularly with the incremental fair value concept. Entities must carefully assess the impact of changes to option terms and calculate any additional fair value provided. By correctly applying the incremental fair value methodology, companies ensure their financial statements accurately reflect the cost of these valuable employee incentives, maintaining transparency and compliance.
Need Help With Your IFRS 2 Valuation?
Our qualified actuaries can help you with discount rate selection, assumption setting, and full IFRS 2 valuations.
Get a Quote